Pretreatment screening and counseling on prolonged erections for patients prescribed trazodone

  title={Pretreatment screening and counseling on prolonged erections for patients prescribed trazodone},
  author={Tejash Shah and Juhi Deolankar and Thaiphi Luu and Hossein Sadeghi-Nejad},
  journal={Investigative and Clinical Urology},
  pages={85 - 89}
Purpose We examined whether patients are appropriately screened for previous prolonged erections or priapism and counseled about trazodone complications, specifically prolonged erections and priapism, prior to trazodone treatment. Materials and Methods We identified patients under the age of 50 on trazodone as of February 27, 2019 at the VA New Jersey Health Care System. Patients were asked about information provided to them prior to medication initiation, occurrence of prolonged erections… 

Tables from this paper

Medications mostly associated with priapism events: assessment of the 2015–2020 Food and Drug Administration (FDA) pharmacovigilance database entries

Patients taking trazodone and/or antipsychotics need to be aware of the priapism-risk; awareness among prescribers would help in reducing priAPism-related detrimental sequelae.



Pathophysiology of prolonged penile erection associated with trazodone use.

Priapism associated with conventional and atypical antipsychotic medications: a review.

Virtually all antipsychotic medications have been reported to rarely cause priapism due to their alpha-adrenergic antagonism, and this adverse event should be considered a urologic emergency.

[Antipsychotic-induced priapism and management challenges: a case report].

Unintentional trazodone overdoses in children ≤6 years of age: data from poison center over a period of 16 years

The clinical effects, dose-related toxicity, and triage dose for acute trazodone ingestions in children ≤6 years of age are characterized and children should be referred for further evaluation in acute unintentional trazoda ingestions with doses ≥6 mg/kg.

Psychotropic Drug-Induced Priapism

Treatment recommendations for psychotropic drug-induced priapism include penile aspiration, irrigation, instillation of vasoactive agents and, if necessary, shunting procedures and patient education with respect to this potentially damaging adverse drug effect.

Priapism associated with atypical antipsychotic medications: a review

Clinicians should monitor patients on these medications for this rare, yet significant side effect and Educating patients about the risk of developing priapism would help increase awareness of the sideeffect and promote early reporting thereby, decreasing long-term morbidity.

Priapism induced by various psychotropics: A case series

  • Timo GreinerMichael Schneider M. Heinze
  • Medicine, Psychology
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2018
Priapism can occur at nearly any age and with any dose, and Clinicians must be aware of the risk and reports of early signs, such as prolonged erections, should be taken seriously.

Recurrent Priapism from Therapeutic Quetiapine

The case of a 43-year-old African American male with a history of schizoaffective disorder who presented to the emergency department multiple times over a three year period with priapism, each episode related to the ingestion of quetiapine is presented.

Psychotropic medication and priapism: a comprehensive review.

It is essential that patients who are to receive psychotropic medications be forewarned about priapism, and patients should be questioned concerning prior occurrence of prolonged erections, since a past history of delayed detumescence is present in approximately 50% of subsequent cases of priapsism.